RJ - BMY: Key Takeaways from Raymond James Fireside Chat - perhaps you will find CMO Samit Hirawat' | BMY Message Board Posts

Bristol-Myers Squibb Co.

  BMY website

BMY   /  Message Board  /  Read Message

 

 






Keyword
Subject
Between
and
Rec'd By
Authored By
Minimum Recs
  
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board
Msg  6383 of 6713  at  3/3/2021 5:39:32 PM  by

Doolen

The following message was updated on 3/3/2021 5:57:56 PM.

 In response to msg 6380 by  JBWIN
view thread

Re: RJ - BMY: Key Takeaways from Raymond James Fireside Chat - perhaps you will find CMO Samit Hirawat's coverage of CELMoDs at Cowen more to your liking, Doolen!

Immensely so.  Read it earlier as I was headed out before just returning.  
 
CFO Elkins will be well served to make note before he is up again on the 9th - and while a possible waste of time, I will reference it to him in an email which will probably not get to him per Polo.
 
I do sincerely believe too much has been being made of the Revlimid LOP revenue impact over the last few years by a number of analysts in light of the Celmod pipeline potential. IMO, addressing that subject properly would be worth several dollars.  
 
Bio's Dr. Sager Tweet and Samit's words warm my heart.  
 
PS - In the words of Salvator Dali ... "When you.ve got it, flaunt it." 
 
 
 


     e-mail to a friend      printer-friendly     add to library      
| More
Recs: 6     Views: 0
Previous Message  Next Message   Post Message   Post a Reply return to message boardtop of board








Financial Market Data provided by
.
Loading...